Sibanye Stillwater : Update on Sibanye-Stillwater’s ongoing COVID-19 vaccination programme

Sibanye Stillwater Limited

Incorporated in the Republic of South Africa

Registration number 2014/243852/06

Share codes: SSW (JSE) and SBSW (NYSE)

ISIN - ZAE000259701

Issuer code: SSW

("Sibanye-Stillwater","the Company" and/or "the Group")

Registered Address:

Constantia Office Park

Bridgeview House • Building 11 • Ground Floor

Cnr 14th Avenue & Hendrik Potgieter Road

Weltevreden Park • 1709

Postal Address:

Private Bag X5 • Westonaria • 1780

Tel [phone] • Fax [phone]

Website:www.sibanyestillwater.com

MEDIA RELEASE

Update on Sibanye-Stillwater's ongoing COVID-19 vaccination programme

Johannesburg, 22 July 2021. Sibanye-Stillwater (Tickers JSE: SSW and NYSE: SBSW) is pleased to report that despite the disruptions which affected parts of South Africa last week, it has made significant progress with the roll out of its COVID-19 vaccination programme in support of the national COVID-19 vaccination effort and aligned with the programmes of other members of the Minerals Council of South Africa.

In accordance with the South African Department of Health (DOH) guidelines and protocols the Group has vaccinated an over 10,000 of its employees (approximately 12% of the South African workforce) since 25 June 2021, testing and validating the efficacy of its vaccination procedures and processes.

Following the success of the initial phase, the vaccine programme is being extended to another four Group health care facilities in three provinces (Gauteng, North West and Free State) with the capacity to administer 2,500 vaccines per day, which is sufficient based on the number of vaccines we are currently receiving. Subject to DOH approvals and the availability of additional vaccines, Sibanye-Stillwater is prepared to accelerate the rollout to its more than 80,000 South African workforce, their dependents and doorstep community members.

Neal Froneman, Chief Executive Officer of Sibanye-Stillwater commenting on the roll out, said: "The successful implementation and progress achieved by this initial stage COVID-19 vaccine programme is extremely pleasing. I am equally pleased by the positive response from our employees and support from other key stakeholders, which are essential to the success of this process."

"Preparations for the vaccine roll out programme began well before DOH accreditation, including training our healthcare employees, acquiring suitable vaccine refrigeration and preparing and implementing appropriate protocols and it is gratifying to observe the positive outcomes and consequences of our actions. As we have previously said, we fully endorse the national vaccination roll out campaign and if provided with sufficient vaccines, will be able to significantly advance the roll out by utilising our other available health care facilities."

For more information on the Sibanye-Stillwater Group, please visit www.sibanyestillwater.com

Investor relations contact:

Email: [e-mail]

James Wellsted

Head of Public relations

1

Tel: [phone]

Website:www.sibanyestillwater.com

Sponsor: J.P. Morgan Equities South Africa Proprietary Limited

FORWARD LOOKING STATEMENTS

The information in this announcement may contain forward-looking statements within the meaning of the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements, including, among others, those relating to Sibanye Stillwater Limited's ("Sibanye-Stillwater" or the "Group") financial positions, business strategies, plans and objectives of management for future operations, are necessarily estimates reflecting the best judgment of the senior management and directors of Sibanye-Stillwater.

All statements other than statements of historical facts included in this announcement may be forward-looking statements. Forward-looking statements also often use words such as "will", "forecast", "potential", "estimate", "expect" and words of similar meaning. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances and should be considered in light of various important factors, including those set forth in this disclaimer. Readers are cautioned not to place undue reliance on such statements.

The important factors that could cause Sibanye-Stillwater's actual results, performance or achievements to differ materially from those in the forward-looking statements include, among others, our future business prospects; financial positions; debt position and our ability to reduce debt leverage; business, political and social conditions in the United States, South Africa, Zimbabwe and elsewhere; plans and objectives of management for future operations; our ability to obtain the benefits of any streaming arrangements or pipeline financing; our ability to service our bond instruments; changes in assumptions underlying Sibanye-Stillwater's estimation of their current mineral reserves and resources; the ability to achieve anticipated efficiencies and other cost savings in connection with past, ongoing and future acquisitions, as well as at existing operations; our ability to achieve steady state production at the Blitz project; the success of Sibanye-Stillwater's business strategy; exploration and development activities; the ability of Sibanye-Stillwater to comply with requirements that they operate in a sustainable manner; changes in the market price of gold, PGMs and/or uranium; the occurrence of hazards associated with underground and surface gold, PGMs and uranium mining; the occurrence of labour disruptions and industrial action; the availability, terms and deployment of capital or credit; changes in relevant government regulations, particularly environmental, tax, health and safety regulations and new legislation affecting water, mining, mineral rights and business ownership, including any interpretations thereof which may be subject to dispute; the outcome and consequence of any potential or pending litigation or regulatory proceedings or other environmental, health and safety issues; power disruptions, constraints and cost increases; supply chain shortages and increases in the price of production inputs; fluctuations in exchange rates, currency devaluations, inflation and other macro-economic monetary policies; the occurrence of temporary stoppages of mines for safety incidents and unplanned maintenance; the ability to hire and retain senior management or sufficient technically skilled employees, as well as their ability to achieve sufficient representation of historically disadvantaged South Africans in management positions; failure of information technology and communications systems; the adequacy of insurance coverage; any social unrest, sickness or natural or man-made disaster at informal settlements in the vicinity of some of Sibanye-Stillwater's operations; and the impact of HIV, tuberculosis and the spread of other contagious diseases, such as coronavirus ("COVID-19"). Further details of potential risks and uncertainties affecting Sibanye-Stillwater are described in Sibanye-Stillwater's filings with the Johannesburg Stock Exchange and the United States Securities and Exchange Commission.

These forward-looking statements speak only as of the date of the content. Sibanye-Stillwater expressly disclaims any obligation or undertaking to update or revise any forward-looking statement (except to the extent legally required).

2